Mature T-Cell and NK-Cell Neoplasm — Trials

Mature T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

825 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 251–300 of 425 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00425555	Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma	completed	Phase 2	139	Novartis PharmaceuticalsINDUSTRY	12	Aug 20, 2021	clinicaltrials
NCT00490776	Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)	terminated	Phase 2	9	Novartis PharmaceuticalsINDUSTRY	1	Aug 18, 2021	clinicaltrials